U.S. Global Investors, Inc. - 10-K Summary (Fiscal Year Ended June 30, 2002)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended June 30, 2002. U.S. Global Investors, Inc. is a Texas corporation engaged in the mutual fund management business. The Company provides investment advisory, transfer agency, mailing, and distribution services to the U.S. Global Investors Funds (USGIF) and U.S. Global Accolade Funds (USGAF). Additionally, the Company engages in proprietary trading and venture capital investments to manage its cash position. The Company operates under the supervision of the SEC and NASD.
Key Financial Metrics
| Metric | Fiscal 2002 | Fiscal 2001 |
|---|---|---|
| Total Revenues | $7,767,514 | $8,893,884 |
| Total Expenses | $8,104,299 | $9,652,382 |
| Net Income (Loss) | $(241,434) | $(794,679) |
| EPS (Basic & Diluted) | $(0.03) | $(0.11) |
| Working Capital | $2,930,974 | $3,246,792 |
| Total Assets | $7,905,021 | $7,912,184 |
| Long-term Obligations | $1,067,967 | $1,135,903 |
| Shareholders' Equity | $5,580,059 | $5,715,520 |
| Cash & Cash Equivalents | $988,936 | $1,333,922 |
Assets Under Management (AUM): Average AUM decreased 8.9% to $1.165 billion, driven by market depreciation and shareholder withdrawals, particularly from the Bonnel Growth Fund.
Material Changes vs. Prior Period
- Net Loss Improvement: The net loss narrowed significantly by 69.7% (from $795k to $241k) primarily due to a 30.7% reduction in General and Administrative expenses and a reduction in expense reimbursements to funds.
- Revenue Decline: Total revenues fell 12.7% year-over-year. Investment advisory fees dropped 7.3% due to lower AUM and market declines. Transfer agent fees decreased 9.9% as the number of shareholder accounts fell from 97,932 to 92,210.
- Investment Income: Investment income swung from a gain of $127k in 2001 to a loss of $168k in 2002, reflecting net realized losses of approximately $49k on securities.
- Expense Reductions: Employee compensation decreased 4.7% due to staff reductions in shareholder communications and marketing. General and administrative expenses dropped $1.3 million, largely due to reduced sub-advisory fees for the Bonnel Growth Fund.
Guidance, Outlook, Risks, and Contingencies
- Contract Renewals: Advisory and transfer agent agreements with USGIF and USGAF expire in February and May 2003, respectively. Management anticipates renewal but notes there is no assurance.
- Liquidity: The Company maintains a current ratio of 3.3 to 1 with approximately $989k in cash and $1.7 million in unencumbered marketable securities. It has access to an unused $1 million credit facility.
- Market Risk: The Company holds significant equity investments ($2.3 million). A hypothetical 25% decrease in market prices would reduce shareholders' equity by approximately $373k.
- Legal Proceedings: The Company is a defendant in a civil lawsuit in New York. Management believes it has strong merits for dismissal and has filed an insurance claim covering the legal expenses.
- Debt Covenants: The Company was not in compliance with certain debt covenants regarding its building mortgage but received a waiver from the bank through June 30, 2002.
- Unusual Items: The Company expensed a $157k receivable related to a previous insurance claim recovery that was deemed unlikely. Additionally, a $104k adjustment was made to mailing service revenues to reflect proper billing volumes.
Investor Verification Checklist
- Contract Renewal Risk: Verify the status of the advisory and transfer agent agreements expiring in early 2003, as these represent the primary revenue source.
- Debt Covenant Compliance: Confirm the Company's ongoing compliance with the bank's financial covenants for the $1.02 million mortgage on its headquarters.
- Asset Under Management Trends: Monitor AUM levels, specifically the impact of continued withdrawals from equity funds versus inflows into gold funds.
- Legal Contingency: Track the outcome of the New York civil lawsuit and the status of the insurance reimbursement.
- Deferred Tax Assets: Review the valuation allowance of $684k against net operating losses (NOLs) to assess the likelihood of future tax benefit realization.